Table 3.
Analyte | Units | Analyte concentration |
Ratio (E/C) | p-Value | AUC | n Epi | n con | |
---|---|---|---|---|---|---|---|---|
Epilepsy | Controls | |||||||
TNF-α | pg/mL | 7.7 ± 2.5 | 5.5 ± 0.4 | ↑ 1.4 | 0.188 | 0.59 | 10 | 25 |
MDC | ng | 2.6 ± 0.4 | 2.2 ± 0.2 | ↑ 1.2 | 0.151 | 0.77 | 8 | 9 |
BDNF | ng | 0.8 ± 0.2 | 1.0 ± 0.2 | ↓ 1.2 | 0.290 | 0.61 | 9 | 10 |
IL-10 | pg/mL | 1.4 ± 0.2 | 1.8 ± 0.3 | ↓ 1.2 | 0.161 | 0.50 | 10 | 25 |
GM-CSF | pg/mL | 1.2 ± 0.3 | 1.4 ± 0.4 | ↓ 1.2 | 0.303 | 0.56 | 10 | 24 |
MCP-1 | pg/mL | 238 ± 41 | 219 ± 13 | ↑ 1.1 | 0.330 | 0.65 | 8 | 9 |
MIP-1β | pg/mL | 66.2 ± 11.7 | 58 ± 6 | ↑ 1.1 | 0.268 | 0.65 | 8 | 9 |
MCP-4 | pg/mL | 388 ± 81 | 367 ± 67 | ↑ 1.1 | 0.419 | 0.52 | 8 | 9 |
IP-10 | pg/mL | 189 ± 47 | 207 ± 38 | ↓ 1.1 | 0.377 | 0.56 | 8 | 9 |
Eotaxin-3 | pg/mL | 5.9 ± 0.8 | 6.4 ± 1.1 | ↓ 1.1 | 0.348 | 0.51 | 8 | 9 |
Eotaxin | pg/mL | 456 ± 128 | 525 ± 105 | ↓ 1·1 | 0.334 | 0.55 | 8 | 9 |